Literature DB >> 12381670

Cannabinoids throw up a conundrum.

DeWayne Townsend1, Stanley A Thayer, David R Brown.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2002        PMID： 12381670      PMCID： PMC1573535          DOI： 10.1038/sj.bjp.0704913

Source DB:  PubMed          Journal:  Br J Pharmacol        ISSN： 0007-1188            Impact factor:   8.739


× No keyword cloud information.
  10 in total

Review 1.  Endocannabinoids as cardiovascular modulators.

Authors:  G Kunos; Z Járai; S Bátkai; S K Goparaju; E J Ishac; J Liu; L Wang; J A Wagner
Journal:  Chem Phys Lipids       Date:  2000-11       Impact factor: 3.329

Review 2.  Identification of the endogenous cannabinoid system through integrative pharmacological approaches.

Authors:  Billy R Martin
Journal:  J Pharmacol Exp Ther       Date:  2002-06       Impact factor: 4.030

3.  The interaction of general anaesthetics and neurosteroids with GABA(A) and glycine receptors.

Authors:  D Belelli; M Pistis; J A Peters; J J Lambert
Journal:  Neurochem Int       Date:  1999-05       Impact factor: 3.921

Review 4.  Central neurocircuitry associated with emesis.

Authors:  P J Hornby
Journal:  Am J Med       Date:  2001-12-03       Impact factor: 4.965

5.  Cannabinoid agonists inhibit the activation of 5-HT3 receptors in rat nodose ganglion neurons.

Authors:  P Fan
Journal:  J Neurophysiol       Date:  1995-02       Impact factor: 2.714

6.  Direct inhibition by cannabinoids of human 5-HT3A receptors: probable involvement of an allosteric modulatory site.

Authors:  M Barann; G Molderings; M Brüss; H Bönisch; B W Urban; M Göthert
Journal:  Br J Pharmacol       Date:  2002-11       Impact factor: 8.739

7.  Neurosteroids modulate nicotinic receptor function in mouse striatal and thalamic synaptosomes.

Authors:  A E Bullock; A L Clark; S R Grady; S F Robinson; B S Slobe; M J Marks; A C Collins
Journal:  J Neurochem       Date:  1997-06       Impact factor: 5.372

8.  Delta 9-tetrahydrocannabinol and cannabinol activate capsaicin-sensitive sensory nerves via a CB1 and CB2 cannabinoid receptor-independent mechanism.

Authors:  Peter M Zygmunt; David A Andersson; Edward D Hogestatt
Journal:  J Neurosci       Date:  2002-06-01       Impact factor: 6.167

9.  The endogenous lipid anandamide is a full agonist at the human vanilloid receptor (hVR1).

Authors:  D Smart; M J Gunthorpe; J C Jerman; S Nasir; J Gray; A I Muir; J K Chambers; A D Randall; J B Davis
Journal:  Br J Pharmacol       Date:  2000-01       Impact factor: 8.739

10.  Comparison of the pharmacology and signal transduction of the human cannabinoid CB1 and CB2 receptors.

Authors:  C C Felder; K E Joyce; E M Briley; J Mansouri; K Mackie; O Blond; Y Lai; A L Ma; R L Mitchell
Journal:  Mol Pharmacol       Date:  1995-09       Impact factor: 4.436
  10 in total
  4 in total

Review 1.  Cannabinoids in supportive care: are they necessary?

Authors:  Eduardo Bruera; Monica Castro
Journal:  Support Care Cancer       Date:  2003-01-22       Impact factor: 3.603

2.  Psychotropic and nonpsychotropic cannabis derivatives inhibit human 5-HT(3A) receptors through a receptor desensitization-dependent mechanism.

Authors:  W Xiong; B-N Koo; R Morton; L Zhang
Journal:  Neuroscience       Date:  2011-04-06       Impact factor: 3.590

Review 3.  Endocannabinoids and the gastrointestinal tract: what are the key questions?

Authors:  G J Sanger
Journal:  Br J Pharmacol       Date:  2007-09-03       Impact factor: 8.739

4.  Cannabinoid receptor-independent inhibition by cannabinoid agonists of the peripheral 5-HT3 receptor-mediated von Bezold-Jarisch reflex.

Authors:  Grzegorz Godlewski; Manfred Göthert; Barbara Malinowska
Journal:  Br J Pharmacol       Date:  2003-03       Impact factor: 8.739
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.